Track topics on Twitter Track topics that are important to you
Tuesday, October 11th 2016 at 12:30pm UTC LYON, France–(BUSINESS WIRE)– Theranexus, a clinical-stage biopharmaceutical company, has announced that it is strengthening its management team t...
Tuesday, September 20th 2016 at 12:19pm UTC Un projet ambitieux de 3,2M EUR sur la validation clinique de l’efficacité du produit THN201 dans le traitement des troubles neurocognitifs dans la malad...
Tuesday, October 4th 2016 at 12:30pm UTC A first step towards the company’s ambition of securing development and marketing of THN102 in the USA LYON, France–(BUSINESS WIRE)– Theranexus, ...
Theranexus has enrolled the first patient for its Phase II clinical study of THN102 to treat excessive daytime sleepiness associated with narcolepsy in adult patients.
Press contactsComCorpAdélaïde Manester+33 1 58 18 32 44 - +33 6 70 45 74 firstname.lastname@example.org Read more...
A first step towards the company’s ambition of securing development and marketing of THN102 in the USA Read more...
Thursday, October 27th 2016 at 12:30pm UTC Cet essai vise à démontrer la supériorité d’efficacité de THN102 par rapport au traitement de référence chez le patient narcoleptique LYON, France...
We have published hundreds of Theranexus news stories on BioPortfolio along with dozens of Theranexus Clinical Trials and PubMed Articles about Theranexus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Theranexus Companies in our database. You can also find out about relevant Theranexus Drugs and Medications on this site too.